サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1215496

尿検査の世界市場：製品別・用途別・エンドユーザー別・検査の種類別の将来予測 (2027年まで)

Urinalysis Market by Product, Application, End User & Test Type - Global Forecast to 2027
出版日: | 発行: MarketsandMarkets | ページ情報: 英文 222 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
尿検査の世界市場：製品別・用途別・エンドユーザー別・検査の種類別の将来予測 (2027年まで)
出版日: 2023年02月07日
発行: MarketsandMarkets
ページ情報: 英文 222 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の尿検査の市場規模は、2022年の39億米ドルから2027年には57億米ドルに達する見通しで、予測期間中のCAGRは8.1%と予測されています。

市場成長の促進要因として、診断用製品の増産や政府の取り組みなどが挙げられます。一方、規制状況の変化など尿検査市場に関連する課題は、この市場の成長を阻害する主な要因となっています。

製品別では、消耗品部門が予測期間中に最も高い成長率で成長する見通しです。研究開発や製品認可の増加、加齢関連の疾患 (腎臓病や肝臓病など) の抑制に注目が集まっていることなどが、市場成長に寄与する大きな要因となっています。

検査の種類別では、予測期間中、妊娠・不妊検査部門の成長率が最も高くなっています。研究資金の増加、女性の不妊・妊娠検査に対する意識の高まり、迅速な妊娠検査の導入の増加が、このセグメントの成長に寄与する主な要因です。

用途別では、予測期間中、疾患スクリーニング分野が最も高い成長率となっています。糖尿病や腎臓病などの疾病予防のための資金調達の増加、診断・画像診断センター数の増加、新興国の医療インフラの改善などが、このセグメントの成長に寄与する主な要因となっています。

エンドユーザー別では、診断検査室部門が最も成長率が高くなっています。新興市場の有利な成長機会や、診断技術に対する規制当局の承認件数の増加、生活習慣関連疾患の発生率の上昇などが、市場成長に寄与する主な要因となっています。

地域別に見ると、アジア太平洋が最も高いCAGRで成長する見通しです。糖尿病の認知度向上に焦点を当てた会議の増加や、各国政府の医療分野への支援政策が、この地域の尿検査市場の成長を後押ししています。

当レポートでは、世界の尿検査の市場について分析し、市場の基本構造や最新情勢、主な市場促進・抑制要因、製品別・検査の種類別・用途別・エンドユーザー別・地域別の市場動向の見通し、市場競争の状態、主要企業のプロファイルなどを調査しております。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題

第6章 尿検査市場：製品別

  • イントロダクション
  • 消耗品
    • 妊娠・不妊治療キット
    • ディップスティック
    • 使い捨て用品
    • 試薬
  • 装置
    • 自動尿分析装置
    • 半自動尿分析装置
    • PoC (ポイントオブケア) 尿分析装置

第7章 尿検査市場：検査の種類別

  • イントロダクション
  • 妊娠・不妊検査
  • 生化学検査
    • 検査室試験
    • POC検査
  • 尿沈査検査

第8章 尿検査市場：用途別

  • イントロダクション
  • 疾患スクリーニング
    • 尿路感染症
    • 腎臓病
    • 糖尿病
    • 肝臓病
    • その他の疾患スクリーニング用途
  • 妊娠・生殖能力

第9章 尿検査市場：エンドユーザー別

  • イントロダクション
  • 診断検査室
  • 病院・クリニック
  • 在宅医療
  • 検査室・研究機関

第10章 尿検査市場：地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • 他の欧州諸国
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 他のアジア太平洋諸国
  • ラテンアメリカ
  • 中東・アフリカ

第11章 競合情勢

  • 概要
  • 主要企業が採用した戦略/有力企業
  • 主要企業の収益シェア分析
  • 市場シェア分析
  • 企業評価クアドラント
  • スタートアップ/中小企業向けの競合リーダーシップマッピング (2021年)
  • 競合ベンチマーキング
  • 競合シナリオ
    • 製品の発売と承認
    • 資本取引

第12章 企業プロファイル

  • 主要企業
    • SIEMENS HEALTHINEERS AG
    • F. HOFFMANN-LA ROCHE LTD.
    • CARDINAL HEALTH, INC.
    • ABBOTT LABORATORIES
    • DANAHER CORPORATION
    • SYSMEX CORPORATION
    • THERMO FISHER SCIENTIFIC, INC.
    • QUIDEL CORPORATION
    • BECTON, DICKINSON AND COMPANY
    • BIO-RAD LABORATORIES, INC.
    • EKF DIAGNOSTICS
  • その他の企業
    • ARKRAY, INC.
    • ACON LABORATORIES, INC.
    • 77 ELEKTRONIKA KFT.
    • URIT MEDICAL ELECTRONIC GROUP CO., LTD.
    • DIRUI INDUSTRIAL CO., LTD.
    • SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
    • BIOBASE GROUP
    • ERBA MANNHEIM
    • ALPHATEC SCIENTIFIC
    • TECO DIAGNOSTICS
    • ANALYTICON BIOTECHNOLOGIES AG
    • BIOWAY BIOTECHNOLOGY
    • HIGH TECHNOLOGY, INC.
    • AGAPPE DIAGNOSTICS
    • GENRUI BIOTECH, INC.
    • SPINREACT S.A.
    • DIALAB GMBH
    • QUANTIMETRIX CORPORATION
    • BIOCARE CORPORATION
    • RANDOX LABORATORIES LTD.
    • PZ CORMAY SA
    • YD DIAGNOSTICS
    • CONTEC MEDICAL SYSTEMS CO., LTD.

第13章 付録

目次
Product Code: MD 3259

The global urinalysis market is projected to reach USD 5.7 billion by 2027 from USD 3.9 billion in 2022, at a CAGR of 8.1% during the forecast period. Market growth is driven by factors such as increased production diagnostic products and government initiatives. On the other hand, challenges associated with urinalysis market like changing regulatory landscapes is the major factors hampering the growth of this market.

"The consumables segment accounted for the highest growth rate in the urinalysis market, by product, during the forecast period"

The urinalysis market is segmented into consumables and instruments. In 2021, consumables segment accounted for the highest growth rate in the urinalysis market. Increase in number of research & development and product approval and increased focus on reducing diseases like kidney and liver disease cases which are also associated with age increased age are major factor contributing to the growth of this segment.

"The pregnancy & fertility tests segment accounted for the highest growth in the urinalysis market, by test type, during the forecast period"

The urinalysis market is segmented into pregnancy & fertility tests, biochemical tests and sediment urinalysis. In 2021, pregnancy & fertility tests segment accounted for the highest growth in the urinalysis market. Increasing funds for research, increasing awareness on fertility and pregnancy testing in women and increasing adoption of rapid pregnancy tests is major factor contributing to the growth of this segment.

"The disease screening segment accounted for the highest growth rate in the urinalysis market, by application, during the forecast period"

The urinalysis market is segmented into disease screening and pregnancy & fertility. In 2021, disease screening segment accounted for the highest growth rate in the urinalysis market. Increasing funding for the prevention of diseases like diabetes and Kidney diseases, growth in the number of diagnostic and imaging centers and improving healthcare infrastructure in emerging countries are major factor contributing to the growth of this segment.

"The diagnostic laboratories segment accounted for the highest growth in the urinalysis market, by end user, during the forecast period"

The urinalysis market is segmented into diagnostic laboratories, hospitals & clinics, home care settings and research laboratories and institutes based on end user. In 2021, the diagnostic laboratories segment accounted for the highest growth rate in the urinalysis market. Emerging markets offer lucrative growth opportunities, growing number of regulatory approvals for diagnostic technologies and rising incidence of life style related disorders are major factors contributing to the growth of this segment.

"Asia Pacific: The fastest-growing region in urinalysis market"

The global urinalysis market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to register the highest CAGR during the forecast period. Increasing number of conferences focused on creating awareness of diabetes and supportive government policies in the healthcare sector is driving the growth of the urinalysis market in this region.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
  • By Designation: C-level - 27%, D-level - 18%, and Others - 55%
  • By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America - 6% , and the Middle East & Africa - 4%

Lists of Companies Profiled in the Report:

  • Siemens Healthineers AG (Germany)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Cardinal Health, Inc. (US)
  • Abbott Laboratories (US)
  • Danaher Corporation (US)
  • Sysmex Corporation (Japan)
  • Thermo Fisher Scientific, Inc. (US)
  • Quidel Corporation (US)
  • Becton, Dickinson and Company (US)
  • Bio-Rad Laboratories, Inc. (US)
  • EKF Diagnostics (UK)

Research Coverage:

This report provides a detailed picture of the global urinalysis market. It aims at estimating the size and future growth potential of the market across different segments, such as product, test type, application, end user and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall urinalysis market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities and challenges.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.3 MARKETS COVERED
    • 1.3.1 URINALYSIS MARKET SEGMENTATION
    • 1.3.2 REGIONAL SCOPE
    • 1.3.3 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
  • 2.2 RESEARCH APPROACH
    • FIGURE 1 URINALYSIS MARKET: RESEARCH DESIGN
    • 2.2.1 SECONDARY DATA
      • 2.2.1.1 Key data from secondary sources
      • 2.2.1.2 Activities involved in secondary research
    • 2.2.2 PRIMARY DATA
      • 2.2.2.1 Primary sources
      • 2.2.2.2 Key data from primary sources
      • 2.2.2.3 Key industry insights
      • 2.2.2.4 Breakdown of primary interviews
    • FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.3 MARKET SIZE ESTIMATION
    • 2.3.1 BOTTOM-UP APPROACH
      • 2.3.1.1 Approach 1: Company revenue estimation
    • FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
      • 2.3.1.2 Approach 2: Company presentations and primary interviews
      • 2.3.1.3 CAGR projections
    • FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    • 2.3.2 TOP-DOWN APPROACH
    • FIGURE 6 URINALYSIS MARKET: TOP-DOWN APPROACH
  • 2.4 DATA TRIANGULATION
    • FIGURE 7 DATA TRIANGULATION METHODOLOGY
  • 2.5 MARKET SHARE ANALYSIS
  • 2.6 STUDY ASSUMPTIONS
  • 2.7 GROWTH RATE ASSUMPTIONS
  • 2.8 RISK ASSESSMENT
    • 2.8.1 RISK ASSESSMENT: URINALYSIS MARKET
  • 2.9 RECESSION IMPACT

3 EXECUTIVE SUMMARY

    • FIGURE 8 URINALYSIS MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
    • FIGURE 9 URINALYSIS MARKET, BY TEST TYPE, 2022 VS. 2027 (USD MILLION)
    • FIGURE 10 URINALYSIS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
    • FIGURE 11 URINALYSIS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
    • FIGURE 12 URINALYSIS MARKET, BY REGION, 2022 VS. 2027 (USD MILLION)

4 PREMIUM INSIGHTS

  • 4.1 URINALYSIS MARKET OVERVIEW
    • FIGURE 13 RISING ADOPTION OF POC DIAGNOSTICS TO SUPPORT MARKET GROWTH DURING FORECAST PERIOD
  • 4.2 URINALYSIS MARKET SHARE, BY PRODUCT, 2022 VS. 2027
    • FIGURE 14 CONSUMABLES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • 4.3 URINALYSIS MARKET SHARE, BY TEST TYPE, 2022 VS. 2027
    • FIGURE 15 BIOCHEMICAL URINALYSIS TO HOLD LARGEST MARKET SHARE DURING FORECAST PERIOD
  • 4.4 URINALYSIS MARKET SHARE, BY APPLICATION, 2022 VS. 2027
    • FIGURE 16 DISEASE SCREENING SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
  • 4.5 URINALYSIS MARKET SHARE, BY END USER, 2022 VS. 2027
    • FIGURE 17 DIAGNOSTICS LABORATORIES TO ACCOUNT FOR DOMINANT MARKET SHARE DURING FORECAST PERIOD
  • 4.6 URINALYSIS MARKET: REGIONAL GROWTH OPPORTUNITIES
    • FIGURE 18 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 19 URINALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing burden of UTIs, diabetes, and liver & kidney diseases to impact market
      • 5.2.1.2 Rising geriatric population and age-associated diseases to fuel market growth
    • TABLE 1 ESTIMATED INCREASE IN GERIATRIC POPULATION, BY REGION (2019-2050)
      • 5.2.1.3 Increasing adoption of POC urine diagnostic tests to drive market
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Availability of refurbished urine analyzers to pose challenges for market
      • 5.2.2.2 High capital investments and lack of skilled laboratory technicians to restrain market growth
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Increasing investments in healthcare and life sciences to fuel growth in emerging markets
      • 5.2.3.2 Technological advancements in urine analyzers to augment market growth
      • 5.2.3.3 Increasing government initiatives and funding for preventive care to provide growth opportunities
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Changing regulatory landscape to challenge market growth

6 URINALYSIS MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 2 URINALYSIS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
  • 6.2 CONSUMABLES
    • TABLE 3 URINALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 4 URINALYSIS MARKET FOR CONSUMABLES, BY REGION, 2020-2027 (USD MILLION)
    • 6.2.1 PREGNANCY & FERTILITY KITS
      • 6.2.1.1 Rapid accessibility and testing convenience to drive market
    • TABLE 5 URINALYSIS MARKET FOR PREGNANCY & FERTILITY KITS, BY REGION, 2020-2027 (USD MILLION)
    • 6.2.2 DIPSTICKS
      • 6.2.2.1 Low cost and standard efficiency to increase use of dipsticks
    • TABLE 6 URINALYSIS MARKET FOR DIPSTICKS, BY REGION, 2020-2027 (USD MILLION)
    • 6.2.3 DISPOSABLES
      • 6.2.3.1 Urine collection cups to drive demand for disposables
    • TABLE 7 URINALYSIS MARKET FOR DISPOSABLES, BY REGION, 2020-2027 (USD MILLION)
    • 6.2.4 REAGENTS
      • 6.2.4.1 Increasing use of controls and calibrators to drive market growth
    • TABLE 8 URINALYSIS MARKET FOR REAGENTS, BY REGION, 2020-2027 (USD MILLION)
  • 6.3 INSTRUMENTS
    • TABLE 9 KEY PRODUCTS IN INSTRUMENTS SEGMENT
    • TABLE 10 URINALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 11 URINALYSIS MARKET FOR INSTRUMENTS, BY REGION, 2020-2027 (USD MILLION)
    • 6.3.1 AUTOMATED URINE ANALYZERS
    • TABLE 12 URINALYSIS MARKET FOR AUTOMATED URINE ANALYZERS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 13 URINALYSIS MARKET FOR AUTOMATED URINE ANALYZERS, BY REGION, 2020-2027 (USD MILLION)
      • 6.3.1.1 Integrated urine analyzers
        • 6.3.1.1.1 Higher workload in hospitals and laboratories to increase adoption of integrated urine analyzers
    • TABLE 14 URINALYSIS MARKET FOR INTEGRATED URINE ANALYZERS, BY REGION, 2020-2027 (USD MILLION)
      • 6.3.1.2 Sediment urine analyzers
    • TABLE 15 URINALYSIS MARKET FOR SEDIMENT URINE ANALYZERS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 16 URINALYSIS MARKET FOR SEDIMENT URINE ANALYZERS, BY REGION, 2020-2027 (USD MILLION)
        • 6.3.1.2.1 Microscopy analyzers
          • 6.3.1.2.1.1 Increased adoption of automated microscopy urine analyzers to drive market growth
    • TABLE 17 URINALYSIS MARKET FOR MICROSCOPY ANALYZERS, BY REGION, 2020-2027 (USD MILLION)
        • 6.3.1.2.2 Flow cytometry analyzers
          • 6.3.1.2.2.1 Accuracy and sensitivity of flow cytometry analyzers to drive adoption
    • TABLE 18 URINALYSIS MARKET FOR FLOW CYTOMETRY ANALYZERS, BY REGION, 2020-2027 (USD MILLION)
      • 6.3.1.3 Biochemical urine analyzers
        • 6.3.1.3.1 Increasing incidence of kidney diseases and UTIs to drive market
    • TABLE 19 URINALYSIS MARKET FOR BIOCHEMICAL URINE ANALYZERS, BY REGION, 2020-2027 (USD MILLION)
    • 6.3.2 SEMI-AUTOMATED URINE ANALYZERS
      • 6.3.2.1 Extensive use of semi-automated urine analyzers in hospitals & clinics to drive segment growth
    • TABLE 20 URINALYSIS MARKET FOR SEMI-AUTOMATED URINE ANALYZERS, BY REGION, 2020-2027 (USD MILLION)
    • 6.3.3 POINT-OF-CARE URINE ANALYZERS
      • 6.3.3.1 Need for rapid testing to drive demand for POC urine analyzers
    • TABLE 21 URINALYSIS MARKET FOR POC URINE ANALYZERS, BY REGION, 2020-2027 (USD MILLION)

7 URINALYSIS MARKET, BY TEST TYPE

  • 7.1 INTRODUCTION
    • TABLE 22 URINALYSIS MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)
  • 7.2 PREGNANCY & FERTILITY TESTS
    • 7.2.1 RISING DEMAND FOR RAPID SELF-CONTAINED TESTS TO DRIVE SEGMENT GROWTH
    • TABLE 23 URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY REGION, 2020-2027 (USD MILLION)
  • 7.3 BIOCHEMICAL TESTS
    • TABLE 24 URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 25 URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY REGION, 2020-2027 (USD MILLION)
    • 7.3.1 LABORATORY TESTS
      • 7.3.1.1 Growing incidence of UTIs and other kidney diseases to drive market
    • TABLE 26 URINALYSIS MARKET FOR LABORATORY TESTS, BY REGION, 2020-2027 (USD MILLION)
    • 7.3.2 POC TESTS
      • 7.3.2.1 Convenience of POC testing to drive segment growth
    • TABLE 27 URINALYSIS MARKET FOR POC TESTS, BY REGION, 2020-2027 (USD MILLION)
  • 7.4 SEDIMENT URINALYSIS
    • 7.4.1 INCREASED ADOPTION OF AUTOMATED ANALYZERS TO DRIVE MARKET GROWTH
    • TABLE 28 URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY TYPE, 2020-2027 (USD MILLION)

8 URINALYSIS MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
    • TABLE 29 URINALYSIS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
  • 8.2 DISEASE SCREENING
    • TABLE 30 URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 31 URINALYSIS MARKET FOR DISEASE SCREENING, BY REGION, 2020-2027 (USD MILLION)
    • 8.2.1 URINARY TRACT INFECTIONS
      • 8.2.1.1 Increasing prevalence of UTIs to drive segment growth
    • TABLE 32 URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY REGION, 2020-2027 (USD MILLION)
    • 8.2.2 KIDNEY DISEASES
      • 8.2.2.1 Rapidly growing geriatric population and prevalence of kidney diseases to fuel segment growth
    • TABLE 33 URINALYSIS MARKET FOR KIDNEY DISEASES, BY REGION, 2020-2027 (USD MILLION)
    • 8.2.3 DIABETES
      • 8.2.3.1 Development of advanced analytical tools for diabetes to drive market growth
    • TABLE 34 URINALYSIS MARKET FOR DIABETES, BY REGION, 2020-2027 (USD MILLION)
    • 8.2.4 LIVER DISEASES
      • 8.2.4.1 High prevalence of liver diseases to fuel segment growth
    • TABLE 35 URINALYSIS MARKET FOR LIVER DISEASES, BY REGION, 2020-2027 (USD MILLION)
    • 8.2.5 OTHER DISEASE SCREENING APPLICATIONS
    • TABLE 36 URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY REGION, 2020-2027 (USD MILLION)
  • 8.3 PREGNANCY & FERTILITY
    • 8.3.1 NEED FOR EARLY DETECTION OF PREGNANCY TO DRIVE SEGMENT
    • TABLE 37 URINALYSIS MARKET FOR PREGNANCY & FERTILITY, BY REGION, 2020-2027 (USD MILLION)

9 URINALYSIS MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 38 URINALYSIS MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 9.2 DIAGNOSTIC LABORATORIES
    • 9.2.1 INCREASED OUTSOURCING OF DIAGNOSTIC TESTS BY HOSPITALS TO LABORATORIES TO AUGMENT MARKET
    • TABLE 39 URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2020-2027 (USD MILLION)
  • 9.3 HOSPITALS & CLINICS
    • 9.3.1 INCREASING ADOPTION OF DIAGNOSTIC TOOLS FOR URINALYSIS TESTING TO DRIVE MARKET
    • TABLE 40 URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2020-2027 (USD MILLION)
  • 9.4 HOME CARE SETTINGS
    • 9.4.1 INCREASING PREFERENCE FOR RAPID TESTING AND CONVENIENCE TO BOOST MARKET
    • TABLE 41 URINALYSIS MARKET FOR HOME CARE SETTINGS, BY REGION, 2020-2027 (USD MILLION)
  • 9.5 RESEARCH LABORATORIES & INSTITUTES
    • 9.5.1 DEVELOPING INNOVATIVE TESTS FOR DISEASE DETECTION TO FUEL MARKET
    • TABLE 42 URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY REGION, 2020-2027 (USD MILLION)

10 URINALYSIS MARKET, BY REGION

  • 10.1 INTRODUCTION
    • TABLE 43 URINALYSIS MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 10.2 NORTH AMERICA
    • FIGURE 20 NORTH AMERICA: URINALYSIS MARKET SNAPSHOT
    • TABLE 44 NORTH AMERICA: URINALYSIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 45 NORTH AMERICA: URINALYSIS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 46 NORTH AMERICA: CONSUMABLES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 47 NORTH AMERICA: INSTRUMENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 48 NORTH AMERICA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 49 NORTH AMERICA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 50 NORTH AMERICA: URINALYSIS MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)
    • TABLE 51 NORTH AMERICA: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 52 NORTH AMERICA: URINALYSIS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 53 NORTH AMERICA: DISEASE SCREENING MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 54 NORTH AMERICA: URINALYSIS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.2.1 RECESSION IMPACT
    • 10.2.2 US
      • 10.2.2.1 Rapid growth of geriatric population to drive market growth
    • TABLE 55 US: URINALYSIS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 56 US: CONSUMABLES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 57 US: INSTRUMENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 58 US: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 59 US: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 60 US: URINALYSIS MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)
    • TABLE 61 US: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 62 US: URINALYSIS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 63 US: DISEASE SCREENING MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 64 US: URINALYSIS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.2.3 CANADA
      • 10.2.3.1 Increasing prevalence of chronic diseases to augment market
    • TABLE 65 CANADA: URINALYSIS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 66 CANADA: CONSUMABLES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 67 CANADA: INSTRUMENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 68 CANADA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 69 CANADA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 70 CANADA: URINALYSIS MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)
    • TABLE 71 CANADA: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 72 CANADA: URINALYSIS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 73 CANADA: DISEASE SCREENING MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 74 CANADA: URINALYSIS MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 10.3 EUROPE
    • TABLE 75 EUROPE: URINALYSIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 76 EUROPE: URINALYSIS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 77 EUROPE: CONSUMABLES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 78 EUROPE: INSTRUMENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 79 EUROPE: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 80 EUROPE: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 81 EUROPE: URINALYSIS MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)
    • TABLE 82 EUROPE: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 83 EUROPE: URINALYSIS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 84 EUROPE: DISEASE SCREENING MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 85 EUROPE: URINALYSIS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.3.1 RECESSION IMPACT
    • 10.3.2 GERMANY
      • 10.3.2.1 Increasing healthcare expenditure to fuel market growth
    • TABLE 86 GERMANY: URINALYSIS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 87 GERMANY: CONSUMABLES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 88 GERMANY: INSTRUMENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 89 GERMANY: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 90 GERMANY: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 91 GERMANY: URINALYSIS MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)
    • TABLE 92 GERMANY: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 93 GERMANY: URINALYSIS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 94 GERMANY: DISEASE SCREENING MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 95 GERMANY: URINALYSIS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.3.3 UK
      • 10.3.3.1 Rising government healthcare expenditure to propel market growth
    • TABLE 96 UK: URINALYSIS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 97 UK: CONSUMABLES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 98 UK: INSTRUMENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 99 UK: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 100 UK: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 101 UK: URINALYSIS MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)
    • TABLE 102 UK: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 103 UK: URINALYSIS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 104 UK: DISEASE SCREENING MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 105 UK: URINALYSIS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.3.4 FRANCE
      • 10.3.4.1 High R&D expenditure to provide growth opportunities
    • TABLE 106 FRANCE: URINALYSIS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 107 FRANCE: CONSUMABLES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 108 FRANCE: INSTRUMENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 109 FRANCE: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 110 FRANCE: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 111 FRANCE: URINALYSIS MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)
    • TABLE 112 FRANCE: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 113 FRANCE: URINALYSIS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 114 FRANCE: DISEASE SCREENING MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 115 FRANCE: URINALYSIS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.3.5 ITALY
      • 10.3.5.1 Large aging population to drive market growth
    • TABLE 116 ITALY: URINALYSIS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 117 ITALY: CONSUMABLES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 118 ITALY: INSTRUMENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 119 ITALY: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 120 ITALY: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 121 ITALY: URINALYSIS MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)
    • TABLE 122 ITALY: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 123 ITALY: URINALYSIS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 124 ITALY: DISEASE SCREENING MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 125 ITALY: URINALYSIS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.3.6 SPAIN
      • 10.3.6.1 Rising geriatric population to propel market
    • TABLE 126 SPAIN: URINALYSIS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 127 SPAIN: CONSUMABLES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 128 SPAIN: INSTRUMENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 129 SPAIN: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 130 SPAIN: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 131 SPAIN: URINALYSIS MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)
    • TABLE 132 SPAIN: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 133 SPAIN: URINALYSIS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 134 SPAIN: DISEASE SCREENING MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 135 SPAIN: URINALYSIS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.3.7 REST OF EUROPE
    • TABLE 136 REST OF EUROPE: URINALYSIS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 137 REST OF EUROPE: CONSUMABLES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 138 REST OF EUROPE: INSTRUMENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 139 REST OF EUROPE: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 140 REST OF EUROPE: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 141 REST OF EUROPE: URINALYSIS MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)
    • TABLE 142 REST OF EUROPE: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 143 REST OF EUROPE: URINALYSIS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 144 REST OF EUROPE: DISEASE SCREENING MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 145 REST OF EUROPE: URINALYSIS MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 10.4 ASIA PACIFIC
    • FIGURE 21 ASIA PACIFIC: URINALYSIS MARKET SNAPSHOT
    • TABLE 146 ASIA PACIFIC: URINALYSIS MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 147 ASIA PACIFIC: URINALYSIS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 148 ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 149 ASIA PACIFIC: INSTRUMENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 150 ASIA PACIFIC: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 151 ASIA PACIFIC: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 152 ASIA PACIFIC: URINALYSIS MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)
    • TABLE 153 ASIA PACIFIC: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 154 ASIA PACIFIC: URINALYSIS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 155 ASIA PACIFIC: DISEASE SCREENING MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 156 ASIA PACIFIC: URINALYSIS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.4.1 RECESSION IMPACT
    • 10.4.2 CHINA
      • 10.4.2.1 Improving healthcare infrastructure in China to support market growth
    • TABLE 157 CHINA: URINALYSIS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 158 CHINA: CONSUMABLES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 159 CHINA: INSTRUMENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 160 CHINA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 161 CHINA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 162 CHINA: URINALYSIS MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)
    • TABLE 163 CHINA: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 164 CHINA: URINALYSIS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 165 CHINA: DISEASE SCREENING MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 166 CHINA: URINALYSIS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.4.3 JAPAN
      • 10.4.3.1 Favorable regulatory framework to drive market growth
    • TABLE 167 JAPAN: URINALYSIS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 168 JAPAN: CONSUMABLES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 169 JAPAN: INSTRUMENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 170 JAPAN: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 171 JAPAN: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 172 JAPAN: URINALYSIS MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)
    • TABLE 173 JAPAN: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 174 JAPAN: URINALYSIS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 175 JAPAN: DISEASE SCREENING MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 176 JAPAN: URINALYSIS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.4.4 INDIA
      • 10.4.4.1 Increasing investment in India's healthcare system to drive market
    • TABLE 177 INDIA: URINALYSIS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 178 INDIA: CONSUMABLES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 179 INDIA: INSTRUMENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 180 INDIA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 181 INDIA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 182 INDIA: URINALYSIS MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)
    • TABLE 183 INDIA: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 184 INDIA: URINALYSIS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 185 INDIA: DISEASE SCREENING MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 186 INDIA: URINALYSIS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.4.5 REST OF ASIA PACIFIC
    • TABLE 187 REST OF ASIA PACIFIC: URINALYSIS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 188 REST OF ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 189 REST OF ASIA PACIFIC: INSTRUMENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 190 REST OF ASIA PACIFIC: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 191 REST OF ASIA PACIFIC: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 192 REST OF ASIA PACIFIC: URINALYSIS MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)
    • TABLE 193 REST OF ASIA PACIFIC: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 194 REST OF ASIA PACIFIC: URINALYSIS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 195 REST OF ASIA PACIFIC: DISEASE SCREENING MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 196 REST OF ASIA PACIFIC: URINALYSIS MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 10.5 LATIN AMERICA
    • TABLE 197 LATIN AMERICA: URINALYSIS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 198 LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 199 LATIN AMERICA: INSTRUMENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 200 LATIN AMERICA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 201 LATIN AMERICA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 202 LATIN AMERICA: URINALYSIS MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)
    • TABLE 203 LATIN AMERICA: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 204 LATIN AMERICA: URINALYSIS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 205 LATIN AMERICA: DISEASE SCREENING MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 206 LATIN AMERICA: URINALYSIS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.5.1 RECESSION IMPACT
  • 10.6 MIDDLE EAST & AFRICA
    • TABLE 207 MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 208 MIDDLE EAST & AFRICA: CONSUMABLES MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 209 MIDDLE EAST & AFRICA: INSTRUMENTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 210 MIDDLE EAST & AFRICA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 211 MIDDLE EAST & AFRICA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 212 MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY TEST TYPE, 2020-2027 (USD MILLION)
    • TABLE 213 MIDDLE EAST & AFRICA: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 214 MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
    • TABLE 215 MIDDLE EAST & AFRICA: DISEASE SCREENING MARKET, BY TYPE, 2020-2027 (USD MILLION)
    • TABLE 216 MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 10.6.1 RECESSION IMPACT

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 STRATEGIES ADOPTED BY KEY PLAYERS/RIGHT TO WIN
    • 11.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS
    • TABLE 217 STRATEGIES DEPLOYED BY KEY COMPANIES
  • 11.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
    • FIGURE 22 REVENUE SHARE ANALYSIS OF TOP PLAYERS
  • 11.4 MARKET SHARE ANALYSIS
    • 11.4.1 URINALYSIS MARKET
    • FIGURE 23 URINALYSIS MARKET SHARE, BY KEY PLAYER (2021)
    • TABLE 218 URINALYSIS MARKET: DEGREE OF COMPETITION
  • 11.5 COMPANY EVALUATION QUADRANT
    • 11.5.1 LIST OF EVALUATED VENDORS
    • 11.5.2 STARS
    • 11.5.3 EMERGING LEADERS
    • 11.5.4 PERVASIVE PLAYERS
    • 11.5.5 PARTICIPANTS
    • FIGURE 24 URINALYSIS MARKET: COMPETITIVE LEADERSHIP MAPPING, 2021
  • 11.6 COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES (2021)
    • 11.6.1 PROGRESSIVE COMPANIES
    • 11.6.2 STARTING BLOCKS
    • 11.6.3 RESPONSIVE COMPANIES
    • 11.6.4 DYNAMIC COMPANIES
    • FIGURE 25 URINALYSIS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES, 2021
  • 11.7 COMPETITIVE BENCHMARKING
    • 11.7.1 PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS
    • FIGURE 26 PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS OF LEADING PLAYERS
    • TABLE 219 URINALYSIS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS
    • TABLE 220 COMPANY PRODUCT FOOTPRINT
    • TABLE 221 COMPANY REGIONAL FOOTPRINT
  • 11.8 COMPETITIVE SCENARIO
    • 11.8.1 PRODUCT LAUNCHES AND APPROVALS
    • TABLE 222 KEY PRODUCT LAUNCHES AND REGULATORY APPROVALS
    • 11.8.2 DEALS
    • TABLE 223 KEY DEALS

12 COMPANY PROFILES

  • (Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) **
  • 12.1 KEY PLAYERS
    • 12.1.1 SIEMENS HEALTHINEERS AG
    • TABLE 224 SIEMENS HEALTHINEERS AG: BUSINESS OVERVIEW
    • FIGURE 27 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2021)
    • 12.1.2 F. HOFFMANN-LA ROCHE LTD.
    • TABLE 225 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW
    • FIGURE 28 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2021)
    • 12.1.3 CARDINAL HEALTH, INC.
    • TABLE 226 CARDINAL HEALTH, INC.: BUSINESS OVERVIEW
    • FIGURE 29 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT (2022)
    • 12.1.4 ABBOTT LABORATORIES
    • TABLE 227 ABBOTT LABORATORIES: BUSINESS OVERVIEW
    • FIGURE 30 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2021)
    • 12.1.5 DANAHER CORPORATION
    • TABLE 228 DANAHER CORPORATION: BUSINESS OVERVIEW
    • FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2021)
    • 12.1.6 SYSMEX CORPORATION
    • TABLE 229 SYSMEX CORPORATION: BUSINESS OVERVIEW
    • FIGURE 32 SYSMEX CORPORATION: COMPANY SNAPSHOT (2022)
    • 12.1.7 THERMO FISHER SCIENTIFIC, INC.
    • TABLE 230 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW
    • FIGURE 33 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2021)
    • 12.1.8 QUIDEL CORPORATION
    • TABLE 231 QUIDEL CORPORATION: BUSINESS OVERVIEW
    • FIGURE 34 QUIDEL CORPORATION: COMPANY SNAPSHOT (2021)
    • 12.1.9 BECTON, DICKINSON AND COMPANY
    • TABLE 232 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
    • FIGURE 35 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2021)
    • 12.1.10 BIO-RAD LABORATORIES, INC.
    • TABLE 233 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
    • FIGURE 36 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2021)
    • 12.1.11 EKF DIAGNOSTICS
    • TABLE 234 EKF DIAGNOSTICS: BUSINESS OVERVIEW
    • FIGURE 37 EKF DIAGNOSTICS: COMPANY SNAPSHOT (2021)
  • 12.2 OTHER PLAYERS
    • 12.2.1 ARKRAY, INC.
    • TABLE 235 ARKRAY, INC.: COMPANY OVERVIEW
    • 12.2.2 ACON LABORATORIES, INC.
    • TABLE 236 ACON LABORATORIES, INC.: COMPANY OVERVIEW
    • 12.2.3 77 ELEKTRONIKA KFT.
    • TABLE 237 77 ELEKTRONIKA KFT.: COMPANY OVERVIEW
    • 12.2.4 URIT MEDICAL ELECTRONIC GROUP CO., LTD.
    • TABLE 238 URIT MEDICAL ELECTRONIC GROUP CO., LTD.: COMPANY OVERVIEW
    • 12.2.5 DIRUI INDUSTRIAL CO., LTD.
    • TABLE 239 DIRUI INDUSTRIAL CO., LTD.: COMPANY OVERVIEW
    • 12.2.6 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
    • TABLE 240 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW
    • 12.2.7 BIOBASE GROUP
    • TABLE 241 BIOBASE GROUP: COMPANY OVERVIEW
    • 12.2.8 ERBA MANNHEIM
    • TABLE 242 ERBA MANNHEIM: COMPANY OVERVIEW
    • 12.2.9 ALPHATEC SCIENTIFIC
    • TABLE 243 ALPHATEC SCIENTIFIC: COMPANY OVERVIEW
    • 12.2.10 TECO DIAGNOSTICS
    • TABLE 244 TECO DIAGNOSTICS: COMPANY OVERVIEW
    • 12.2.11 ANALYTICON BIOTECHNOLOGIES AG
    • TABLE 245 ANALYTICON BIOTECHNOLOGIES AG: COMPANY OVERVIEW
    • 12.2.12 BIOWAY BIOTECHNOLOGY
    • TABLE 246 BIOWAY BIOTECHNOLOGY: COMPANY OVERVIEW
    • 12.2.13 HIGH TECHNOLOGY, INC.
    • TABLE 247 HIGH TECHNOLOGY, INC.: COMPANY OVERVIEW
    • 12.2.14 AGAPPE DIAGNOSTICS
    • TABLE 248 AGAPPE DIAGNOSTICS: COMPANY OVERVIEW
    • 12.2.15 GENRUI BIOTECH, INC.
    • TABLE 249 GENRUI BIOTECH, INC.: COMPANY OVERVIEW
    • 12.2.16 SPINREACT S.A.
    • TABLE 250 SPINREACT S.A.: COMPANY OVERVIEW
    • 12.2.17 DIALAB GMBH
    • TABLE 251 DIALAB GMBH: COMPANY OVERVIEW
    • 12.2.18 QUANTIMETRIX CORPORATION
    • TABLE 252 QUANTIMETRIX CORPORATION: COMPANY OVERVIEW
    • 12.2.19 BIOCARE CORPORATION
    • TABLE 253 BIOCARE CORPORATION: COMPANY OVERVIEW
    • 12.2.20 RANDOX LABORATORIES LTD.
    • TABLE 254 RANDOX LABORATORIES LTD.: COMPANY OVERVIEW
    • 12.2.21 PZ CORMAY SA
    • TABLE 255 PZ CORMAY SA: COMPANY OVERVIEW
    • 12.2.22 YD DIAGNOSTICS
    • TABLE 256 YD DIAGNOSTICS: COMPANY OVERVIEW
    • 12.2.23 CONTEC MEDICAL SYSTEMS CO., LTD.
    • TABLE 257 CONTEC MEDICAL SYSTEMS CO., LTD.: COMPANY OVERVIEW
  • *Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS